CoChat
Sign Up
Cited by 26

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Prospective Attitudes towards Respiratory Syncytial Virus (RSV) Vaccination: Validation of a Survey Instrument among Young Females in Jordan Pending Vaccine Authorization

Kherfan, Tleen, Sallam, Malik·2023·Vaccines
DOI 10.3390/vaccines11081386
Open this paper in CoChat — free account

Abstract

In May 2023, the U.S. FDA advisors endorsed Pfizer’s pregnancy-administered vaccine (branded ABRYSVO) to protect infants from respiratory syncytial virus (RSV) infection. Vaccination can reduce the burden of RSV-related respiratory disease, with previous studies showing its substantial medical and financial burden in Jordan. However, pregnant women may exhibit hesitancy to get vaccinated due to concerns about potential risks to themselves or their fetuses. This study aimed to assess the acceptance of the RSV vaccine among young females and identify the determinants influencing their decision using a newly constructed instrument. A survey instrument was developed and validated, comprising 26 items to measure RSV vaccine acceptance. A cross-sectional study design was employed, with data collection from a sample of females aged 18 to 45 residing in Jordan during 5–6 July 2023, using a convenient approach via an online distributed questionnaire. The final study sample comprised 315 respondents, with 67.6% who have heard of RSV before the study. If the vaccine was safe, effective, and provided freely, 70.2% showed willingness to get the RSV vaccine, 15.2% resisted, and 14.6% were hesitant. Principal component analysis identified six internally consistent sub-scales with the following suggested themes: Advice, Burden, Conspiracy, Dangers, Efficiency, and Fear, comprising 21 items collectively as assigned as the “ABCDEF” scale for RSV vaccine acceptance. RSV vaccine acceptance in this study was associated with the advice and fear constructs. The validated survey instrument successfully captured important determinants of RSV vaccine acceptance among young females. RSV vaccine promotion efforts should focus on the following: enhancing vaccine education, improving trust in healthcare institutions and providers, reducing burdens through resolving cost issues and focusing on the role of social support, addressing safety concerns, and tailoring communication strategies to effectively promote the benefits of the vaccine. These insights can inform public health policies and interventions aiming to promote RSV vaccination and mitigate the burden of RSV-related diseases among infants. Follow-up studies are recommended with pregnant women as the target group to assess their attitude towards RSV vaccination and to confirm the validity of the conceived ABCDEF survey instrument.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/vaccines11081386

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 102

  1. Bennett, J.E., Dolin, R., and Blaser, M.J. (2015). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, W.B. Saunders. [8th ed.].
  2. Shi, 2017, Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study, Lancet, 390, 946, 10.1016/S0140-6736(17)30938-8 · DOI
  3. Gatt, D., Martin, I., AlFouzan, R., and Moraes, T.J. (2023). Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV). Pathogens, 12. · DOI
  4. Hall, 2009, The burden of respiratory syncytial virus infection in young children, N. Engl. J. Med., 360, 588, 10.1056/NEJMoa0804877 · DOI
  5. Riccò, M., Baldassarre, A., Provenzano, S., Corrado, S., Cerviere, M.P., Parisi, S., Marchesi, F., and Bottazzoli, M. (2022). Infodemiology of RSV in Italy (2017–2022): An Alternative Option for the Surveillance of Incident Cases in Pediatric Age?. Children, 9. · DOI
  6. Hansen, 2022, Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018, JAMA Netw. Open, 5, e220527, 10.1001/jamanetworkopen.2022.0527 · DOI
  7. Riccò, M., Corrado, S., Palmieri, S., and Marchesi, F. (2023). Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022). Children, 10. · DOI
  8. Cerviere, 2022, Respiratory Syncytial Virus: An Uncommon Cause of Febrile Seizures-Results from a Systematic Review and Meta-Analysis, Pediatr. Rep., 14, 464, 10.3390/pediatric14040055 · DOI
  9. Corrado, 2023, Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians, Pediatr. Rep., 15, 154, 10.3390/pediatric15010013 · DOI
  10. Lawrence, 2018, Severe outcomes associated with respiratory viruses in newborns and infants: A prospective viral surveillance study in Jordan, BMJ Open, 8, e021898, 10.1136/bmjopen-2018-021898 · DOI
  11. Williams, 2010, Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan, Scand. J. Infect. Dis., 42, 368, 10.3109/00365540903496544 · DOI
  12. Mejias, 2020, The journey to a respiratory syncytial virus vaccine, Ann. Allergy Asthma Immunol., 125, 36, 10.1016/j.anai.2020.03.017 · DOI
  13. Higgins, 2016, Advances in RSV vaccine research and development—A global agenda, Vaccine, 34, 2870, 10.1016/j.vaccine.2016.03.109 · DOI
  14. Esposito, 2022, RSV Prevention in All Infants: Which Is the Most Preferable Strategy?, Front. Immunol., 13, 880368, 10.3389/fimmu.2022.880368 · DOI
  15. Eichinger, 2021, Strategies for active and passive pediatric RSV immunization, Ther. Adv. Vaccines Immunother., 9, 2515135520981516, 10.1177/2515135520981516 · DOI
  16. Esposito, 2016, Antibody response to respiratory syncytial virus infection in children <18 months old, Hum. Vaccin. Immunother., 12, 1700
  17. Acosta, 2015, Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease, Clin. Vaccine Immunol., 23, 189, 10.1128/CVI.00609-15 · DOI
  18. Castilow, 2007, Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease, Immunol. Res., 39, 225, 10.1007/s12026-007-0071-6 · DOI
  19. Etti, 2022, Maternal vaccination: A review of current evidence and recommendations, Am. J. Obs. Gynecol., 226, 459, 10.1016/j.ajog.2021.10.041 · DOI
  20. Baraldi, 2022, RSV disease in infants and young children: Can we see a brighter future?, Hum. Vaccines Immunother., 18, 2079322, 10.1080/21645515.2022.2079322 · DOI
  21. Kampmann, 2023, Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants, N. Engl. J. Med., 388, 1451, 10.1056/NEJMoa2216480 · DOI · Paper page
  22. Center, 2022, Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy, N. Engl. J. Med., 386, 1615, 10.1056/NEJMoa2106062 · DOI
  23. Ngwuta, 2015, Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera, Sci. Transl. Med., 7, 309ra162, 10.1126/scitranslmed.aac4241 · DOI
  24. Madhi, 2020, Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants, N. Engl. J. Med., 383, 426, 10.1056/NEJMoa1908380 · DOI
  25. Biagi, C., Dondi, A., Scarpini, S., Rocca, A., Vandini, S., Poletti, G., and Lanari, M. (2020). Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines. Vaccines, 8. · DOI
  26. Ananworanich, J., and Heaton, P.M. (2021). Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities. Vaccines, 9. · DOI
  27. Hsu, 2022, Sources of Vaccine Hesitancy: Pregnancy, Infertility, Minority Concerns, and General Skepticism, Open Forum. Infect. Dis., 9, ofab433, 10.1093/ofid/ofab433 · DOI
  28. Larson, 2022, Defining and measuring vaccine hesitancy, Nat. Hum. Behav., 6, 1609, 10.1038/s41562-022-01484-7 · DOI
  29. Gagnon, 2015, Strategies intended to address vaccine hesitancy: Review of published reviews, Vaccine, 33, 4191, 10.1016/j.vaccine.2015.04.041 · DOI
  30. Dutta, 2021, Gender-responsive language in the National Policy Guidelines for Immunization in Kenya and changes in prevalence of tetanus vaccination among women, 2008–2009 to 2014: A mixed methods study, Women’s Stud. Int. Forum., 86, 102476, 10.1016/j.wsif.2021.102476 · DOI
  31. Cunningham, 2019, Development of a Spanish version of the parent attitudes about childhood vaccines survey, Hum. Vaccin. Immunother., 15, 1106, 10.1080/21645515.2019.1578599 · DOI
  32. Skjefte, 2021, COVID-19 vaccine acceptance among pregnant women and mothers of young children: Results of a survey in 16 countries, Eur. J. Epidemiol., 36, 197, 10.1007/s10654-021-00728-6 · DOI
  33. Shen, 2019, Addressing vaccine hesitancy: Clinical guidance for primary care physicians working with parents, Can. Fam. Physician., 65, 175
  34. Oduwole, E.O., Pienaar, E.D., Mahomed, H., and Wiysonge, C.S. (2022). Overview of Tools and Measures Investigating Vaccine Hesitancy in a Ten Year Period: A Scoping Review. Vaccines, 10. · DOI
  35. Larson, 2015, Measuring vaccine hesitancy: The development of a survey tool, Vaccine, 33, 4165, 10.1016/j.vaccine.2015.04.037 · DOI
  36. Luyten, 2019, Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument, Vaccine, 37, 2494, 10.1016/j.vaccine.2019.03.041 · DOI
  37. Martin, 2017, Understanding the Dimensions of Anti-Vaccination Attitudes: The Vaccination Attitudes Examination (VAX) Scale, Ann. Behav. Med., 51, 652, 10.1007/s12160-017-9888-y · DOI
  38. Opel, 2011, Development of a survey to identify vaccine-hesitant parents: The parent attitudes about childhood vaccines survey, Hum. Vaccin., 7, 419, 10.4161/hv.7.4.14120 · DOI
  39. ElSayed, D.A., Bou Raad, E., Bekhit, S.A., Sallam, M., Ibrahim, N.M., Soliman, S., Abdullah, R., Farag, S., and Ghazy, R.M. (2022). Validation and Cultural Adaptation of the Parent Attitudes about Childhood Vaccines (PACV) Questionnaire in Arabic Language Widely Spoken in a Region with a High Prevalence of COVID-19 Vaccine Hesitancy. Trop. Med. Infect. Dis., 7. · DOI
  40. Shapiro, 2016, Validation of the vaccine conspiracy beliefs scale, Papillomavirus. Res., 2, 167, 10.1016/j.pvr.2016.09.001 · DOI
  41. Hautvast, 2022, A systematic literature review to clarify the concept of vaccine hesitancy, Nat. Hum. Behav., 6, 1634, 10.1038/s41562-022-01431-6 · DOI
  42. Sallam, 2022, A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review, J. Multidiscip. Heal., 15, 21, 10.2147/JMDH.S347669 · DOI
  43. Bhattacharya, 2022, COVID-19 vaccine hesitancy among pregnant women: A systematic review and meta-analysis, BMJ Open, 12, e061477, 10.1136/bmjopen-2022-061477 · DOI
  44. Azami, M., Nasirkandy, M.P., Esmaeili Gouvarchin Ghaleh, H., and Ranjbar, R. (2022). COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis. PLoS ONE, 17. · DOI
  45. Wong, 2016, Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: A systematic review, Vaccine, 34, 20, 10.1016/j.vaccine.2015.11.020 · DOI
  46. Yuen, 2014, Determinants of uptake of influenza vaccination among pregnant women—A systematic review, Vaccine, 32, 4602, 10.1016/j.vaccine.2014.06.067 · DOI
  47. Januszek, S.M., Faryniak-Zuzak, A., Barnaś, E., Łoziński, T., Góra, T., Siwiec, N., Szczerba, P., Januszek, R., and Kluz, T. (2021). The Approach of Pregnant Women to Vaccination Based on a COVID-19 Systematic Review. Medicina, 57. · DOI
  48. Smith, 2022, Weighing up the risks—Vaccine decision-making in pregnancy and parenting, Women Birth, 35, 547, 10.1016/j.wombi.2022.02.007 · DOI
  49. Sarantaki, A., Kalogeropoulou, V.E., Taskou, C., Nanou, C., and Lykeridou, A. (2022). COVID-19 Vaccination and Related Determinants of Hesitancy among Pregnant Women: A Systematic Review and Meta-Analysis. Vaccines, 10. · DOI
  50. MacCallum, 1999, Sample size in factor analysis, Psychol. Methods, 4, 84, 10.1037/1082-989X.4.1.84 · DOI · Paper page
  51. Venkatesan, 2023, First RSV vaccine approvals, Lancet Microbe, 4, e577, 10.1016/S2666-5247(23)00195-7 · DOI
  52. Wise, 2023, First RSV vaccine for older adults is approved in Europe, BMJ, 381, 978, 10.1136/bmj.p978 · DOI
  53. Papi, 2023, Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults, N. Engl. J. Med., 388, 595, 10.1056/NEJMoa2209604 · DOI
  54. Bont, 2022, Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries, Front. Pediatr., 10, 1033125, 10.3389/fped.2022.1033125 · DOI
  55. Baral, 2021, Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model, BMJ Open, 11, e046563, 10.1136/bmjopen-2020-046563 · DOI
  56. Li, 2022, Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis, Lancet, 399, 2047, 10.1016/S0140-6736(22)00478-0 · DOI
  57. Wouters, 2021, Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment, Lancet, 397, 1023, 10.1016/S0140-6736(21)00306-8 · DOI
  58. Wittenauer, R., Pecenka, C., and Baral, R. (2023). Cost of childhood RSV management and cost-effectiveness of RSV interventions: A systematic review from a low- and middle-income country perspective. BMC Med., 21. · DOI
  59. Mahmud, S., Baral, R., Sanderson, C., Pecenka, C., Jit, M., Li, Y., and Clark, A. (2023). Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: A decision-support model for use in low-income and middle-income countries. BMC Med., 21. · DOI
  60. Anderson, 2013, Strategic priorities for respiratory syncytial virus (RSV) vaccine development, Vaccine, 31, B209, 10.1016/j.vaccine.2012.11.106 · DOI
  61. Larson, 2022, The Vaccine-Hesitant Moment, N. Engl. J. Med., 387, 58, 10.1056/NEJMra2106441 · DOI
  62. Pollard, 2021, A guide to vaccinology: From basic principles to new developments, Nat. Rev. Immunol., 21, 83, 10.1038/s41577-020-00479-7 · DOI · Paper page
  63. Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., and Böhm, R. (2018). Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE, 13. · DOI
  64. Ophir, 2022, Vaccine Hesitancy Under the Magnifying Glass: A Systematic Review of the Uses and Misuses of an Increasingly Popular Construct, Health Commun., 38, 2106, 10.1080/10410236.2022.2054102 · DOI
  65. Nuwarda, R.F., Ramzan, I., Weekes, L., and Kayser, V. (2022). Vaccine Hesitancy: Contemporary Issues and Historical Background. Vaccines, 10. · DOI
  66. Larson, 2022, Vaccines and the social amplification of risk, Risk Anal., 42, 1409, 10.1111/risa.13942 · DOI
  67. Wood, 2023, Promoting COVID-19 vaccine confidence through public responses to misinformation: The joint influence of message source and message content, Soc. Sci. Med., 324, 115863, 10.1016/j.socscimed.2023.115863 · DOI
  68. Sturgis, 2021, Trust in science, social consensus and vaccine confidence, Nat. Hum. Behav., 5, 1528, 10.1038/s41562-021-01115-7 · DOI
  69. Sallam, M., Ghazy, R.M., Al-Salahat, K., Al-Mahzoum, K., AlHadidi, N.M., Eid, H., Kareem, N., Al-Ajlouni, E., Batarseh, R., and Ababneh, N.A. (2022). The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic. Vaccines, 10. · DOI
  70. Hong, 2023, COVID-19 vaccine communication and advocacy strategy: A social marketing campaign for increasing COVID-19 vaccine uptake in South Korea, Humanit. Soc. Sci. Commun., 10, 109, 10.1057/s41599-023-01593-2 · DOI
  71. Mahameed, H., Al-Mahzoum, K., AlRaie, L.A., Aburumman, R., Al-Naimat, H., Alhiary, S., Barakat, M., Al-Tammemi, A.a.B., Salim, N.A., and Sallam, M. (2023). Previous Vaccination History and Psychological Factors as Significant Predictors of Willingness to Receive Mpox Vaccination and a Favorable Attitude towards Compulsory Vaccination. Vaccines, 11. · DOI
  72. Treglia, 2021, The Influence of Health Beliefs, of Resources, of Vaccination History, and of Health Anxiety on Intention to Accept COVID-19 Vaccination, Front. Psychol., 12, 729803, 10.3389/fpsyg.2021.729803 · DOI
  73. Baldassarre, 2023, Vaccine Hesitancy in Women of Childbearing Age and Occupational Physicians: Results from a Cross-Sectional Study (Italy, 2022), Women, 3, 237, 10.3390/women3020019 · DOI
  74. Ali, 2022, Vaccine equity in low and middle income countries: A systematic review and meta-analysis, Int. J. Equity Health, 21, 82, 10.1186/s12939-022-01678-5 · DOI · Paper page
  75. Phelps, 2023, Perceptions of social circle vaccine acceptance and COVID-19 vaccine initiation among postpriority vaccine eligible adults, Health Psychol., 42, 276, 10.1037/hea0001287 · DOI
  76. Bertin, 2020, Conspiracy Beliefs, Rejection of Vaccination, and Support for hydroxychloroquine: A Conceptual Replication-Extension in the COVID-19 Pandemic Context, Front. Psychol., 11, 565128, 10.3389/fpsyg.2020.565128 · DOI
  77. Pummerer, 2022, Antecedents and consequences of COVID-19 conspiracy beliefs: A systematic review, Soc. Sci. Med., 301, 114912, 10.1016/j.socscimed.2022.114912 · DOI
  78. Shapiro, 2018, Using an integrated conceptual framework to investigate parents’ HPV vaccine decision for their daughters and sons, Prev. Med., 116, 203, 10.1016/j.ypmed.2018.09.017 · DOI
  79. Coelho, 2022, Increased belief in vaccination conspiracy theories predicts increases in vaccination hesitancy and powerlessness: Results from a longitudinal study, Soc. Sci. Med., 315, 115522, 10.1016/j.socscimed.2022.115522 · DOI
  80. Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N.A., Bakri, F.G., and Mahafzah, A. (2021). High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries. Vaccines, 9. · DOI · Paper page
  81. Alsanafi, 2023, Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs, Hum. Vaccin. Immunother., 19, 2194772, 10.1080/21645515.2023.2194772 · DOI
  82. Sallam, M., Al-Mahzoum, K., Eid, H., Assaf, A.M., Abdaljaleel, M., Al-Abbadi, M., and Mahafzah, A. (2021). Attitude towards HPV Vaccination and the Intention to Get Vaccinated among Female University Students in Health Schools in Jordan. Vaccines, 9. · DOI
  83. Amiebenomo, O.M., Osuagwu, U.L., Envuladu, E.A., Miner, C.A., Mashige, K.P., Ovenseri-Ogbomo, G., Abu, E.K., Timothy, C.G., Ekpenyong, B.N., and Langsi, R. (2023). Acceptance and Risk Perception of COVID-19 Vaccination among Pregnant and Non Pregnant Women in Sub-Saharan Africa: A Cross-Sectional Matched-Sample Study. Vaccines, 11. · DOI
  84. Anderson, 2021, Maternal vaccines during the Covid-19 pandemic:A qualitative interview study with UK pregnant women, Midwifery, 100, 103062, 10.1016/j.midw.2021.103062 · DOI
  85. Jaffe, 2020, Pregnant women’s perceptions of risks and benefits when considering participation in vaccine trials, Vaccine, 38, 6922, 10.1016/j.vaccine.2020.08.059 · DOI
  86. Palmer, 2016, Optimizing Participation of Pregnant Women in Clinical Trials: Factors Influencing Decisions About Participation in Medication and Vaccine Trials, J. Obs. Gynaecol. Can., 38, 945, 10.1016/j.jogc.2016.04.100 · DOI
  87. Zampetakis, 2021, The health belief model predicts vaccination intentions against COVID-19: A survey experiment approach, Appl. Psychol. Health. Well. Being., 13, 469, 10.1111/aphw.12262 · DOI
  88. Patwary, M.M., Bardhan, M., Disha, A.S., Hasan, M., Haque, M.Z., Sultana, R., Hossain, M.R., Browning, M.H.E.M., Alam, M.A., and Sallam, M. (2021). Determinants of COVID-19 Vaccine Acceptance among the Adult Population of Bangladesh Using the Health Belief Model and the Theory of Planned Behavior Model. Vaccines, 9. · DOI
  89. Ellingson, 2019, Enhancing uptake of influenza maternal vaccine, Expert. Rev. Vaccines, 18, 191, 10.1080/14760584.2019.1562907 · DOI
  90. Larson, 2012, The globalization of risk and risk perception: Why we need a new model of risk communication for vaccines, Drug Saf., 35, 1053, 10.1007/BF03261991 · DOI
  91. Bahri, 2018, Listen to the public and fulfil their information interests—Translating vaccine communication research findings into guidance for regulators, Br. J. Clin. Pharmacol., 84, 1696, 10.1111/bcp.13587 · DOI
  92. Ferraro, 2022, Respiratory Syncytial Virus in Pregnant Women: Systematic Review and Meta-Analysis, Women, 2, 147, 10.3390/women2020016 · DOI
  93. Galagali, 2022, Vaccine Hesitancy: Obstacles and Challenges, Curr. Pediatr. Rep., 10, 241, 10.1007/s40124-022-00278-9 · DOI
  94. Badell, 2022, Covid-19 vaccination in pregnancy, Bmj, 378, e069741, 10.1136/bmj-2021-069741 · DOI
  95. Riepl, 2023, The surge of RSV and other respiratory viruses among children during the second COVID-19 pandemic winter season, Front. Pediatr., 11, 1112150, 10.3389/fped.2023.1112150 · DOI
  96. Kandeel, A., Fahim, M., Deghedy, O., Roshdy, W.H., Khalifa, M.K., Shesheny, R.E., Kandeil, A., Naguib, A., Afifi, S., and Mohsen, A. (2023). Resurgence of influenza and respiratory syncytial virus in Egypt following two years of decline during the COVID-19 pandemic: Outpatient clinic survey of infants and children, October 2022. BMC Public Health, 23. · DOI
  97. Broor, 2018, Respiratory syncytial virus infections in India: Epidemiology and need for vaccine, Indian J. Med. Microbiol., 36, 458, 10.4103/ijmm.IJMM_19_5 · DOI
  98. Biggs, 2023, Respiratory Syncytial Virus Infection among Hospitalized Infants in Four Middle-Income Countries, J. Pediatr. Infect. Dis. Soc., 12, 394, 10.1093/jpids/piad042 · DOI
  99. Marschalko, 2021, Psychological Predictors of COVID-19 Prevention Behavior in Hungarian Women Across Different Generations, Front. Psychol., 12, 596543, 10.3389/fpsyg.2021.596543 · DOI
  100. Dutta, T., Agley, J., and Xiao, Y. (2022, January 14–16). College Student COVID-19 Vaccination Prevalence and Context: A ‘Pulse’ Survey Conducted Before and After Formal Statewide Rollout. Proceedings of the American Public Health Association 2022 Annual Meeting and Expo, Boston, MA, USA.
  101. Bendau, 2021, COVID-19 vaccine hesitancy and related fears and anxiety, Int. Immunopharmacol., 97, 107724, 10.1016/j.intimp.2021.107724 · DOI
  102. Jenkins, D., and Bosch, F.X. (2020). Human Papillomavirus, Academic Press. Chapter 22.

Metadata

Authors
Kherfan, T., & Sallam, M.
Venue
Vaccines
Publisher
MDPI AG
Published
2023-08-19
Volume
11
Issue
8
Pages
1386
ISSN
2076-393X
DOI
10.3390/vaccines11081386
Cited by
26
References
4
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review